BioMarin to Participate in Two Upcoming Virtual Investor Conferences
BioMarin Pharmaceutical (NASDAQ: BMRN) announced participation in two virtual conferences, with live audio webcasts available for investors. The webcasts can be accessed at biomarin.com. An archived version will also be accessible post-conference. BioMarin focuses on developing therapies for rare disorders, boasting a portfolio of six commercial products and various clinical candidates. For more details, visit their website.
- None.
- None.
SAN RAFAEL, Calif., May 18, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual conferences. An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: | |
Investors | Media |
Traci McCarty | Debra Charlesworth |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (415) 455-7451 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301293332.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
What conferences will BioMarin participate in May 2021?
Where can I watch BioMarin's conference webcasts?
What is the focus of BioMarin Pharmaceutical?
How many products does BioMarin offer?